Nepra Foods Announces Delay in Filing Annual Financial Statements
The Company's auditors require additional time to complete their audit and, as a result, the Annual Filings were not filed before the Filing Deadline. The Company is working diligently with its accounting staff and external auditors to file the Annual Filings as soon as practicable and currently expects to be able to file the Annual Filings on or before August 29, 2025.
The Company has applied to the applicable Canadian securities regulatory authorities and received a management cease trade order related to the Company's securities to be imposed against the Chief Executive Officer and Chief Financial Officer of the Company to trade securities of the Company. The management cease trade order will be in effect until the Annual Filings are filed and requires that the Annual Financial Filings be filed on or before September 29, 2025.
Until the Annual Filings are filed, the Company intends to provide information in accordance with National Policy 12-203 Management Cease Trade Orders for as long as the Annual Filings remain outstanding, including the issuance of bi-weekly default status reports in the form of a news release, if applicable.
About Nepra Foods Inc.
Nepra Foods is a specialty food company focused on innovative and proprietary allergen and gluten-free food ingredient technologies. The company supports food manufacturers globally with formulations, ingredients and technical support for the production of the next generation of healthy, nutritious foods. For more information on the company, visit www.neprafoods.com.
ON BEHALF OF THE BOARD OF DIRECTORS
William Hogan, CEO & Director
[email protected]
844-566-1917
The CSE has neither approved nor disapproved the contents of this news release. The CSE does not accept responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains statements and information that, to the extent that they are not historical fact, constitute 'forward-looking information' within the meaning of applicable securities legislation. Forward-looking information is based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.
Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, but not limited to, statements relating to the Company's financial performance, business development, results of operations, and those listed in filings made by the Company with the Canadian securities regulatory authorities (which may be viewed at www.sedarplus.ca ). Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company's management to predict all of such factors and to assess in advance the impact of each such factor on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking information to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws.
SOURCE: Nepra Foods
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
4 minutes ago
- Bloomberg
Elevating Investor Relations: Evolving tools for corporate intelligence
Welcome to Elevating Investor Relations, Bloomberg's series on the evolving role of corporate investor relations. As the amount of data density available to any organization increases exponentially with time, so too does the challenge of drilling down into it to find strategically actionable insight. In this article, we will explore how to leverage this data as a source of competitive edge for investor relations (IR) teams. From insight to influence For a modern IR team, deriving an edge from data means more than just knowing which investors are buying or selling their company's stock: it means having a firm grip on exactly what competitors and peers are doing and saying, whether that's the details from their latest figures or the finer points from a potentially disruptive product launch. Not only can that intelligence go to inform their company's future disclosures and pre-empt the questions that investors will ask at the next opportunity, but it can be fed back into internal channels to drive better strategic making and improve IR's standing. A recent survey of IROs by the Canadian Investor Relations Institute (CIRI) found this aspect of the role has grown to be a recognized part of the IR team's mandate, with 95 percent of IROs reporting that they regularly gather information on their company's market competitors. Nearly two thirds of IROs report that their intelligence-gathering effort feeds senior management's strategic discussions and decision-making, while 61 percent say it informs IR strategy and 22 percent regularly provide competitive intelligence to board members. Legacy of insight Notably, the notion of having competitive intelligence to operate from is nothing new. Competitors have been seeking any information they can get their hands on to achieve a competitive advantage over their rivals for as long as the marketplace has been open. In the history of public companies, competitive intelligence took on a more structured form in the 20th century, when companies founded dedicated market research departments to collect and analyze information about not just their own customer preferences. By 1983, Motorola CEO Bob Galvin had established one of the world's first formal corporate competitive intelligence divisions, which produced a 'steady stream of well-sourced intelligence analyses on competitors' moves, industry and market evolution, and technology trends', according to the Journal of US Intelligence Studies. Smarter tools Today, the rise of data and the tools to extract insights are helping companies keep up real-time monitoring of their competitors and market dynamics. For IROs, who are already so plugged into what the market says and feels about their organizations (and about their rivals), the continued evolution of competitive intelligence can help them drive those decisions first-hand. While common sources of intelligence include external databases, competitors' publications and other market data, advanced corporate finance tools can give issuers even deeper insights that skilled IROs can readily turn into new sources of edge above their peers and rivals. These tools include: Customer relationship management (CRM) tools – on a simple level, these allow IR teams to keep track of their investors, the meetings they have held with them and any notes they want associated. These are increasingly being fed into by other data tools to create fuller investor profiles, including relevant analyst information, driving factors behind their buy or hold decisions and much more. Real-time market analytics – fetching information from the markets in real-time, whether concerning your own companies, those in your immediate peer group or those further afield. Analysis using these tools is becoming increasingly sophisticated, with platforms like Bloomberg's terminal allowing IR teams to analyze how companies rank or key metrics like earnings, fair value estimates or ESG performance, and compare performance across individual business lines or CSR initiatives. Stock surveillance – using market data to monitor critical market movements and emerging trends actively, as they occur, to allow IR teams to oversee strategic responses, or to help further hone their outgoing market communications for maximum impact. Investor targeting – using this same real-time data to give insights into the buy-side's biggest institutions, allowing IR teams to see which investors might make a good match for them. Tools like the Bloomberg Terminal allow you to see who owns your stock and peers, track what they're trading and follow corporate activism and proxy votes. Analyst insights – taking stock of the sell-side's research, estimates and recommendations to both identify any deviations between what an analyst says and what a company's reality is, or giving IR teams the power to identify any weak points in their messaging and derive measures to counteract them. The Bloomberg Terminal allows IR teams to compare recommendations side-by-side and refine by price target, period, total return rankings and more. Data visualization – to augment this powerful suite of tools, many IROs use powerful charting software to visualize key data and help present it to various stakeholder audiences, whether that's getting internal buy-in from senior management or presenting granular insights to investors and analysts to help drive their understanding of their companies. To see how leading IR teams drive excellence through storytelling, click here. Each of these tools can help IR teams drive competitive edge on their own, but when combined – with comparable data able to be shared between them – IR professionals are put in the driving seat, able to make strategic decisions with the data they need to back it up. How can we help?
Bloomberg
4 minutes ago
- Bloomberg
Tesla to Award Musk $30B in Stock
Tesla has approved an interim stock award worth around $30 billion for CEO Elon Musk, aiming to keep him focused on the electric vehicle maker. Bloomberg's Max Chafkin joins Caroline Hyde and Ed Ludlow on 'Bloomberg Tech.' (Source: Bloomberg)
Yahoo
32 minutes ago
- Yahoo
Watch These Novo Nordisk Stock Price Levels After Last Week's 33% Drop
Key Takeaways Novo Nordisk's U.S.-listed shares were slightly higher in recent trading after shedding a third of their value last week, when the company cut its full-year outlook and named a new CEO. The shares had resumed their steep downtrend last week on above-average volume, indicating selling conviction from larger market participants. Investors should watch major support levels on Novo Nordisk's chart around $36 and $29, while also monitoring key overhead areas near $60 and $ Nordisk's (NVO) U.S.-listed shares were up about 2% in recent trading after shedding about a third of their value last week, when the company cut its full-year outlook and named a new CEO, leading Wall Street analysts to downgrade the stock. Since hitting a record high in June last year, Novo Nordisk shares have lost roughly two-thirds of their value, pressured by increasing competition from rival Eli Lilly's (LLY) weight-loss drugs and challenges during trials of the company's next-generation obesity drugs. Below, we take a closer look at Novo Nordisk's weekly chart and use technical analysis to identify major price levels that investors will likely be watching after last week's dramatic sell-off. An Extended Downtrend With last week's drop, Novo Nordisk shares resumed their steep downtrend on above-average trading volume, indicating selling conviction from larger market participants. The sell-off coincided with the relative strength index (RSI) falling to its lowest levels since early May, signaling weakening price momentum, though the indicator neared its oversold threshold, increasing the chances for short-term bounces. It's also worth noting that the 50-week moving average continues to converge toward the 200-week MA, potentially setting the stage for an ominous death cross, a bearish pattern that forecasts lower prices. Let's identify two major support levels on Novo Nordisk's chart worth watching if selling resumes this week and also point out several key overhead areas to monitor during potential recovery efforts. Major Support Levels Worth Watching The first major lower level to watch sits around $36. This area would likely provide support near the upper range of a consolidation period that formed on the chart between October 2020 and April 2021. A more significant move lower could see the shares test lower support at the $29 level. Investors may look for buying opportunities in this area near a horizontal line that connects a range of corresponding price action on the chart between January 2018 and April 2020. Key Overhead Areas to Monitor An initial recovery effort could see the shares climb to overhead resistance around $60. The price may encounter selling pressure in this area near the prominent April trough and April 2022 peak. A more bullish upswing opens the door for a rally toward $78. Investors who have bought Novo Nordisk shares at lower levels may decide to lock in profits in this location near the June peak, which closely aligns with the completion of a pullback in July 2023. The comments, opinions, and analyses expressed on Investopedia are for informational purposes only. Read our warranty and liability disclaimer for more info. As of the date this article was written, the author does not own any of the above securities. Read the original article on Investopedia Sign in to access your portfolio
